Palm oil versus hydrogenated soybean oil: Effects on serum lipids and plasma haemostatic variables

Asia Pacific Journal of Clinical Nutrition

Volumn 14, Issue 4, 2005, Pages 348-357

  Pedersen, Jan I ^a   Müller, Hanne ^b   Seljeflot, Ingebjørg ^c   Kirkhus, Bente ^d  

^a UNIVERSITY OF OSLO   (Norway)

^b NORWEGIAN UNIVERSITY OF LIFE SCIENCES   (Norway)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^d Mills DA   (Norway)

Author keywords

Coronary heart disease; Fibrinolysis; Hydrogenated soybean oil; Palm oil; Palmitic acid; Plasma haemostatic variables; Serum cholesterol; Serum lipids; Trans fatty acids

Indexed keywords

GLYCINE MAX;

EID: 32344437414     PISSN: 09647058     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Sambanthamurthi R, Sundram K, Tan Y-A. Chemistry and biochemistry of palm oil. Prog Lipid Res 2000; 39: 507-558.
2. Hegsted DM, McGandy RB, Myers ML, Stare FJ. Quantitative effects of dietary fat on serum cholesterol in man. Am J Clin Nutr 1965; 17: 281-295.
3. Nestel P, Noakes M, Belling B, McArthur R, Clifton P, Janus E, Abbey M. Plasma lipoprotein lipid and Lp(a) changes with substitution of elaidic acid for oleic acid in the diet. J Lipid Res 1992; 33: 1029-1036.
4. Ng T KW, Hassan K, Lim JB, Lye MS, Ishak R. Nonhypercholesterolemic effects of a palm-oil diet in Malaysian volunteers. Am J Clin Nutr 1991; 53: 1015S-1020S.
5. Ng TKW, Hayes KC, DeWitt GF, Jegathesan M, Satgunasingam N, Ong ASH, Tan D. Dietary palmitic and oleic acids exert similar effects on serum cholesterol and lipoprotein profiles in normocholesterolemic men and women. J Am Coll Nutr 1992; 1: 383-390.
6. Marzuki A, Arshad F, Razak TA, Jaarin K. Influence of dietary fat on plasma lipid profiles of Malaysian adolescents. Am J Clin Nutr 1991;53:1010S-14S.
7. Choudhury N, Tan L, Truswell S. Comparison of palmolein and olive oil: effects on plasma lipids and vitamin E in young adults. Am J Clin Nutr 1995; 61: 1043-1051.
8. Temme EHM, Mensink RP, Hornstra G. Comparison of the effects of diets enriched in lauric, palmitic, or oleic acids on serum lipids and lipoproteins in healthy women and men. Am J Clin Nutr 1966; 3: 897-903.
9. Hayes KC, Pronczuk A, Lindsey S, Diersen-Schade D. Dietary saturated fatty acids (12:0, 14:0, 16:0) differ in their impact on plasma cholesterol and lipoproteins in nonhuman primates. Am J Clin Nutr 1991; 53: 491-498.
10. Sundram K, Ismail A, Hayes KC, Jeyamalar R, Pathmanathan R. Trans (elaidic) fatty acids adversely affect the lipoprotein profile relative to specific saturated fatty acids in humans. J Nutr 1997; 127: 514S-520S.
11. Müller H, Jordal O, Kierulf P, Kirkhus B, Pedersen JI. Replacement of partially hydrogenated soybean oil by palm oil in margarine without unfavourable effects on serum lipids. Lipids 1998; 33: 879-887.
12. Müller H, Seljeflot I, Solvoll K, Pedersen JI. Patially hydrogenated soybean oil reduces postprandial t-PA activity compared with palm oil. Atherosclerosis 2001; 155: 467-476.
13. Keys A, Anderson JT, Grande F. Prediction of serum-cholesterol responses of man to change in fats in the diet. Lancet 1957; 2: 959-966.
14. Brussaard JH, Katan MB, Groot PHE, Havekes LM, Hautwast AJ. Serum lipoproteins of healthy persons fed a low-fat diet or a polyunsaturated fat diet for three months. A comparison of two cholesterol-lowering diets. Atherosclerosis 1982; 42: 205-219.
15. Mensink RP, Katan MB. Effect of monounsaturated fatty acids versus complex carbohydrates on high density lipoproteins in healthy men and women. Lancet 1987; 1: 122-125.
16. Energy and Protein Requirements. Report of a Joint FAO/WHO/UNU Expert Consultation. Technical Report Series 724. World Health Organization, Geneva 1985.
17. Almendingen K, Jordal O, Kierulf P, Sanstad B, Pedersen J I. Effects of partially hydrogenated fish oil, partially hydrogenated soybean oil, and butter on serum lipoproteins and Lp(a) in men. J Lipid Res 1995; 36: 1370-1384.
18. rd ed. Vol. 8, Weinheim, FRG, 1985; 139-148.
19. rd ed. Vol. 8, Weinheim, FRG, 1985; 12-18.
20. Friedewald WT, Lewy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
21. Sundram K, Hayes KC, Siru OH. Dietary palmitic acid results in lower serum cholesterol than does a lauric-myristic combination in normolipemic humans. Am J Clin Nutr 1994; 59: 841-846.
22. Müller H, Kirkhus B, Pedersen JI. Serum cholesterol predictive equations with special emphasis on trans and saturated fatty acids. An analysis from designed controlled studies. Lipids 2001; 36: 783-791.
23. Wood R, Kubena K, Tseng S, Martin G, Crook R. Effect of palm oil, margarine, butter and sunflower oil on the serum lipids and lipoproteins of normocholesterolemic middle-aged men. J Nutr Biochem 1993; 4: 286-297.
24. Judd JT, Clevidence BA, Muesing RA, Wittes J, Sunkin ME, PodcZasy JJ. Dietary trans fatty acids: Effect on plasma lipids and lipoproteins of healthy men and women. Am J Clin Nutr 1994; 59: 861-868.
25. Mensink RP, Katan MB. (1990) Effect of Dietary Trans Fatty Acids on High-Density and Low-Density Lipoprotein Cholesterol Levels in Healthy Subjects: N Engl J Med 1990; 323: 439-445.
26. Zock PL, Katan MB. Hydrogenation alternatives: Effects of trans fatty acids and stearic acid versus linoleic acid on serum lipids and lipoproteins in humans. J Lipid Res 1992; 33: 399-410.
27. Troisi R, Willett WC, Weiss ST. (1992) Trans-fatty acid intake in relation to serum lipid concentrations in adult men. Am J Clin Nutr 1992; 56: 1019-1024.
28. Mensink RP, Zock PL, Kester ADM, Katan MB. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr 2003; 77: 1146-1155
29. Abbey M, Noakes M, Belling GB, Nestel PJ. Partial replacement of saturated fatty acids with almonds or walnuts lowers total plasma cholesterol and low-density-lipoprotein cholesterol. Am J Clin Nutr 1994; 59: 995-999.
30. Cox C, Mann J, Sutherland W, Chrisholm A, Skeaff M. Effects of coconut oil, butter, and safflower oil on lipids and lipoproteins in persons with moderately elevated cholesterol levels. J Lipid Res 1995; 36: 1787-1795.
31. Wood R, Kubena K, O'Brien B, Tseng S, Martin G. Effect of butter, mono- and polyunsaturated fatty acid-enriched butter, trans fatty acid margarine, and zero irans fatty acid margarine on serum lipids and lipoproteins in healthy men. J Lipid Res 1993; 34: 1-11.
32. Miller NE, Førde OH, Thelle DS, Mjøs OD. The Tromsø Heart Study. High-density lipoprotein and coronary hearth disease - a prospective case-control study, Lancet 1977; 1(8019): 965-967.
33. Gordon DJ, Probstfield JL, Garrison RJ. High-density lipoprotein cholesterol and cardiovascular disease: Four prospective American studies. Circulation. 1989; 79: 8-15.
34. Anderson KM, Wilson PWF, Odell PM, Kannel WB. An updated coronary risk profile: A statement for health professionals. Circulation 1991; 83: 356-362.
35. Hu FB, Stampfer MJ, Manson JE, Rimm E, Colditz GA, Rosner BA, Hennekens CH, Willet WC. Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med 1997; 337: 1491-1499.
36. Siguel EN, Lerman LH. Trans-fatty acid patterns in patients with angiographically documented coronary artery disease. Am J Cardiol 1993; 71: 916-920.
37. Ascherio A, Hennekens CH, Buring JE, Master C, Stampfer MJ, Willet WS. Trans-fatty acids intake and risk of myocardial infarction. Circulation 1994; 89: 94-101.
38. Ridker PM, Vaughan DE, Stampfer MJ, Manson JE, Hennekens CH. Endogenous tissue-type plasminogen activator and risk of myocardial infarction. Lancet 1993; 341: 1165-1168.
39. Thompson SG, Kienast J, Pyke SDM, Haverkate F, van de Loo JCW. for the European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study group. Haemostatic factors and risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med 1995; 332: 635-641.
40. Smith EB. Haemostatic factors and atherogenesis. Atherosclerosis 1996; 124: 137-43.
41. FitzGerald GA, Barry P. Dietary factors in thrombosis and hemostasis: summary and conclusions. Am J Clin Nutr 1997; 65 (suppl): 1699S-1701S.
42. Salomaa V, Stinson V, Kark JD, Folsom AR, Davis CE, Wu KK. Association of fibrinolytic parameters with earley atherosclerosis. Circulation 1995; 91: 284-290.
43. Hamsten A, Wiman B, de Faire U, Blombäck M. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med 1985; 313: 1557-1563.
44. Meade TW, Mellows S, Brozovic M, Miller GJ, Chakrabarti RR, North WRS, Haines AP, Stirling Y, Imeson JD, Thompson SG. Haemostatic function and ishaemic heart disease: principal results of the Northwick Park Hearth Study (NPHS). Lancet 1986; 2(8506): 533-537.
45. Ridker PM. An epidemiological assessment of thrombotic risk factors for cardiovascular disease. Curr Opin Lipidol 1992; 3: 285-290.
46. Wiezorek I, Ludlam CA, Fox KAA. Tissue-type plasminogen activator and plasminogen activator inhibitor activities as predictors of adverse events in unstable angina. Am J Cardiol 1994; 74: 424-429
47. Jansson JH, Nilsson TK, Olofsson BO. Tissue plasminogen activator and other risk factors as predictors of cardiovascular events in patients with severe angina pectoris. Eur Heart J 1991; 12: 157-161.
48. Geppert A, Beckmann S, Graf R, Hornykewycz S, Lang I, Schuster E, Binder BR, Huber K. Tissue-type plasminogen activator and type-1 plasminogen activator inhibitor in patients with coronary artery disease - Relations to clinical variables and cardiovascular risk factors. Fibrinolysis 1995; 9 suppl 1: 109-113.
49. Hamsten A, Walldius G, Szamosi A, Blombäck M, de Faire U, Dahlen G, Landou C, Wiman B. Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet 1987; 2: 3-9.
50. Pearson TA, LaCava J, Weil HFC. Epidemiology of thrombotic-hemostatic factors and their associations with cardiovascular disease. Am J Clin Nutr 1997; 65: 1764S-1782S.
51. Mutanen M, Aro A. Coagulation and fibrinolysis factors in healthy subjects consuming high stearic or trans fatty acid diets. Thromb Haemost 1997; 77: 99-104.
52. Sanders TAB, Oakley FR, Crook D, Cooper JA, Miller GJ. High intakes of trans monounsaturated fatty acids taken for 2 weeks do not influence procoagulant and fibrinolytic risk markers for CHD in young healthy men. Brit J Nutr 2003; 89: 767-776.